Myofibroblastic Sarcoma

2014 ◽  
pp. 345-350
Author(s):  
Marco Gambarotti
Keyword(s):  
Myofibroblastic Sarcoma

A Case of Cutaneous Low-grade Myofibroblastic Sarcoma

2001 ◽  
Vol 28 (7) ◽  
pp. 383-387 ◽  
Author(s):  
Sung-Eun Chang ◽  
Jee-Ho Choi ◽  
Kyung-Jeh Sung ◽  
Kee-Chan Moon ◽  
Jai-Kyoung Koh ◽  
...  
Keyword(s):  
Low Grade ◽  
Myofibroblastic Sarcoma

Histopathological and Immunohistochemical Diagnosis of Low-Grade Myofibroblastic Sarcoma

2018 ◽  
Vol 126 (3) ◽  
pp. e94
Author(s):  
Jussara Maria Gonçalves ◽  
Ana Guadalupe Gama Cuellar ◽  
Emanuely Da Silva Chrun ◽  
Luiz Henrique Godoi Marola ◽  
Daniella Serafin Couto Vieira ◽  
...  
Keyword(s):  
Low Grade ◽  
Myofibroblastic Sarcoma ◽  
Immunohistochemical Diagnosis

Myofibroblastic sarcoma of the mandible: a case report

2012 ◽  
Vol 38 (4) ◽  
pp. 240 ◽  
Author(s):  
Kyung-Ran Park ◽  
Hyo Won Jang ◽  
Ji-Hoon Won ◽  
Hyun-Sil Kim ◽  
In-Ho Cha ◽  
...  
Keyword(s):  
Case Report ◽  
Myofibroblastic Sarcoma

scholarly journals Low-grade myofibroblastic sarcoma of the pancreas: A case report and literature review

2018 ◽  
Vol 14 (10) ◽  
pp. 796 ◽  
Author(s):  
Weidong Xiao ◽  
Long Peng ◽  
Yi Tu ◽  
Yong Li
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Low Grade ◽  
Myofibroblastic Sarcoma

scholarly journals Limbal, low-grade myofibroblastic sarcoma: Case report and literature review

2020 ◽  
Vol 68 (11) ◽  
pp. 2538
Author(s):  
Kaustubh Mulay ◽  
Mrittika Sen ◽  
SantoshG Honavar
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Low Grade ◽  
Myofibroblastic Sarcoma

scholarly journals The chemotherapy and radiation in low-grade myofibroblastic sarcoma: is there a role?

2020 ◽  
Author(s):  
Yao Xu ◽  
Guijun Xu ◽  
Xin Wang ◽  
Min Mao ◽  
Haixiao Wu ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Surgical Treatment ◽  
Head And Neck ◽  
Radiation Treatment ◽  
Treatment Strategies ◽  
Neck Region ◽  
Low Grade ◽  
Myofibroblastic Sarcoma ◽  
Kaplan Meier ◽  
Cox Proportional Hazard Regression

Abstract Background: Low-grade myofibroblastic sarcoma (LGMS) is a rare entity with a predilection in the head and neck. There are still no optimal treatment strategies for LGMS. We aimed to investigate the role of chemotherapy and radiation treatment for LGMS. Survival estimate was performed and prognostic factors were identified.Methods: Based on the Surveillance, Epidemiology, and End Result (SEER) database, LGMS patients diagnosed between 2001 and 2015 were involved in our study. Kaplan-Meier curves and log-rank tests were used to estimate overall survival. Cox proportional hazard regression model was performed to identify prognostic factors.Results: A total of 96 eligible patients with LGMS were included, among which 86 (89.6%) received surgical treatment. Twenty-eight (29.2%) patients received radiation treatment while chemotherapy was offered to 20 (10.4%) patients. The median age was 55.0 years old with 22 cases occurred in head and neck region. The mean OS was 125.2 (95%CI 106.3-144.2) months while 1-, 3-, 5- and 10-year OS rates were 88%, 77%, 70% and 59%, respectively. Age older than 60 years, positive nodal status and no surgical treatment were independent prognostic factors for patients with LGMS. Chemotherapy and radiation were not independent prognostic factors for LGMS.Conclusions: Several prognostic factors for LGMS were revealed in this study. Surgical resection is the main therapy while chemotherapy and radiation showed limited effects on survival improvement. Thus, chemotherapy and/or radiation should not be routinely performed in LGMS.

scholarly journals High‐grade myofibroblastic sarcoma of the pleura: A case report and literature review

2020 ◽  
Vol 11 (10) ◽  
pp. 3011-3014
Author(s):  
Ruizhi Zhao ◽  
Jianyang Wang ◽  
Hongtu Zhang ◽  
Yihebali Chi ◽  
Nan Bi
Keyword(s):  
Case Report ◽  
Literature Review ◽  
High Grade ◽  
Myofibroblastic Sarcoma
Sign in / Sign up

Export Citation Format

Share Document